PCT LTD Announces New Financial Officer Appointment 10:48

New Post Public Reply Private Reply Replies (0) Message Board
CyberC
357
PCT LTD Announces New Financial Officer Appointment
10:48 am ET May 14, 2021 (BusinessWire) Print
PCT LTD (OTC INK "PCTL" announced today that Arthur E. Abraham has been appointed Chief Financial Officer, effective May 17, 2021. Abraham will succeed Sheldon Smith, J.D., CPA, whose new role will be overseeing the compliance of PCT LTD's SEC filings and contract law.

Abraham, 66, served as chief financial officer for various private and public organizations, as well as regional and corporate controller for manufacturing and distribution giants such as Haagen-Dazs and SYSCO. Abraham is a proven financial leader with a solid track record of delivering profitable growth for various businesses.

"I am pleased to welcome Abraham to our leadership team," said Gary Grieco, PCT LTD's CEO and Chairman. Grieco further commented, "His deep and extensive experience in leading the financial operations of various businesses - as well as driving operational changes - will make an immediate impact as we effectively manage through the current economic challenges and continue to position the Company for future endeavors. I am confident Abraham will provide strong leadership and is an excellent addition to our team."

Art Abraham, CFO, stated, "I am thrilled to join PCT LTD, a company I admire as an innovative organization with unique strengths, a strong business model and a proud history. I look forward to working with the team to execute the company's priorities, accelerate its growth and enhance value for shareholders and all stakeholders."

As CFO, Abraham will lead PCTL's finance organization, ultimately responsible for accounting, treasury, financial planning and analysis, as well as taxes. Abraham holds a bachelor's degree in Finance and Business Administration from Marshall University in Huntington, WVA.

About PCT LTD:

PCT LTD ("PCTL" focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The company acquires and holds rights to innovative products and technologies, which are commercialized through its operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp).

ADDITIONAL NEWS AND CORPORATE UPDATES:

PCTL would like to warn its stockholders and potential investors that material corporate information regarding sales, areas of business and other corporate updates will only be made through press releases or filings with the SEC and through Twitter (PCTL@PCTL_). PCTL does not utilize social media, chatrooms or other online sources to disclose material information. The public should only rely on official press releases, Tweets from the Company's official Twitter account, and corporate filings for accurate and up to date information regarding PCTL.

Forward-Looking Statements:

This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements."

Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: PCTL's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCTL to execute its business plan; the anticipated results of business contracts with regard to revenue; and any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCTL makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the SEC. PCTL undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

www.para-con.com www.pctcorphealth.com www.pctcorporation.com Twitter: https://mobile.twitter.com/PCTL_

View source version on businesswire.com: https://www.businesswire.com/news/home/20210514005381/en/

SOURCE: PCT LTD">

Investor Relations Contact
Andrew Barwicki
(516) 662-9461
andrew@barwicki.com
or
IR@para-con.com

PCT Ltd. (PCTL) Stock Research Links

PCTL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 497

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 264

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 414

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 452

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 536

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 298

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 477

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 239

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 368

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Shifts Away from Tech: Insights on Russell 2000 Stocks

Updated Category News Views 238

Indices: Mixed Signals as Investors Shift Focus US equity index futures remain steady after a recent market rotation. While the S&P 500 ended flat, the Nasdaq 100 experienced a slight decline as investors adjusted their portfolios, particularly moving away from high-profile technology stocks. However, the Dow showed resilience, bolstered by robust performance in defense...

Continue Reading
Kagurabachi Anime Unveils Star Cast and Production Team

Updated Category News Views 21

Embarking on a New Anime Adventure Kagurabachi is the latest sensation gearing up to hit the anime airwaves, and boy, does it come with quite the pedigree. This isn't just another blip on the Weekly Shonen Jump lineup. Nope, it's a full-throttle affair mean't to slash its way into our hearts—and maybe wallets, but more on that later. The Cast That Packs a Punch Miku...

Continue Reading
Introducing Lefty™: An Innovative Drink for Left-Handed Athletes

Updated Category News Views 369

Introducing Lefty™: An Innovative Drink for Left-Handed Athletes Finally, there's a sports drink that acknowledges the unique challenges faced by left-handed individuals in a world designed for right-handers. Pickle Juice® has unveiled Lefty™, a revolutionary beverage tailored to left-handed athletes, addressing issues from awkward packaging to the frustration of...

Continue Reading
Urgent Call for Governance Reforms at Grifols by Flat Footed LLC

Updated Category News Views 183

Flat Footed LLC's Concerns About Grifols' Governance Flat Footed LLC, a notable investment manager, is making headlines for urging Grifols, S.A. to reconsider its governance strategy. Holding a significant 4.64% stake in the company, Flat Footed aims to enhance transparency and align the interests of shareholders. Letter to the Board of Directors Recently, Flat Footed LLC...

Continue Reading
Piramal Pharma Limited Reports Strong Q2 and H1 FY25 Results

Updated Category News Views 176

Piramal Pharma Limited Reports Strong Q2 and H1 FY25 Results Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a prominent global pharmaceuticals and wellness entity, has outlined its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) concluded in September 2024. The company has demonstrated impressive growth in key financial metrics,...

Continue Reading